Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRSN

Mersana Therapeutics

$15.32

0.46 (3.10%)

07:06
02/15/18
02/15
07:06
02/15/18
07:06
Initiation
Mersana Therapeutics initiated at H.C. Wainwright »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

Over a month ago
MRSN

Mersana Therapeutics

$16.98

1.17 (7.40%)

08:11
12/12/17
12/12
08:11
12/12/17
08:11
Hot Stocks
Mersana Therapeutics doses first patient dosed with XMT-1536 in study »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MRSN

Mersana Therapeutics

$16.81

-0.19 (-1.12%)

13:45
11/14/17
11/14
13:45
11/14/17
13:45
Conference/Events
Mersana Therapeutics has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MRSN

Mersana Therapeutics

$16.81

-0.19 (-1.12%)

04:55
11/14/17
11/14
04:55
11/14/17
04:55
Conference/Events
Mersana Therapeutics has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MRSN

Mersana Therapeutics

$17.10

-0.81 (-4.52%)

09:13
11/10/17
11/10
09:13
11/10/17
09:13
Conference/Events
Mersana Therapeutics has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MRSN

Mersana Therapeutics

$14.95

-0.35 (-2.29%)

07:32
10/30/17
10/30
07:32
10/30/17
07:32
Hot Stocks
Mersana Therapeutics announces FDA clearance of XMT-1536 IND application »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$15.15

-0.08 (-0.53%)

07:06
08/11/17
08/11
07:06
08/11/17
07:06
Earnings
Mersana Therapeutics reports Q2 EPS ($6.33), may not compare to consensus (69c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:25
07/24/17
07/24
06:25
07/24/17
06:25
Initiation
Mersana Therapeutics initiated at Leerink »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:21
07/24/17
07/24
06:21
07/24/17
06:21
Initiation
Mersana Therapeutics initiated at JPMorgan »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$14.05

-0.14 (-0.99%)

06:10
07/24/17
07/24
06:10
07/24/17
06:10
Initiation
Mersana Therapeutics initiated at Cowen »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.